Cytosorbents (CTSO) Work In Process (2023 - 2026)

Cytosorbents' Work In Process history runs 4 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• Quarterly Work In Process rose 99.66% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 99.66% YoY) and the FY2025 annual result came in at $1.0 million, up 101.59% from the prior year.
• Work In Process was $1.2 million for Q1 2026 at Cytosorbents, up from $1.0 million in the prior quarter.
• Across five years, Work In Process topped out at $1.2 million in Q1 2026 and bottomed at $503000.0 in Q4 2024.
• A 4-year average of $875775.3 and a median of $838871.0 in 2023 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2024 — Work In Process plunged 40.04% — and 2025, when it jumped 101.59%.
• Cytosorbents' Work In Process stood at $838871.0 in 2023, then plunged by 40.04% to $503000.0 in 2024, then jumped by 101.59% to $1.0 million in 2025, then advanced by 22.39% to $1.2 million in 2026.
• Business Quant data shows CTSO's Work In Process at $1.2 million in Q1 2026, $1.0 million in Q4 2025, and $1.1 million in Q3 2025.